Apogee Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Apogee Therapeutics, Inc. (APGE) reported Increase (Decrease) in Other Noncurrent Assets of $1.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-10
- Apogee Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $2.09M, a 37.75% increase year-over-year.
- Apogee Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$155.00K, a 102.27% decline year-over-year.
- Apogee Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$73.00K.
- Apogee Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $181.00K, a 293.48% increase year-over-year.
- Apogee Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $8.47M, a 8628.87% increase from fiscal 2024.
- Apogee Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $97.00K, a 9.35% decline from fiscal 2023.
- Apogee Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $107.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.94M 10-Q · filed 2026-08-10 | $1.86M derived: sum of 3 quarters · filed 2026-08-10 | $2.04M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$155.00K 10-Q · filed 2026-05-11 | -$228.00K derived: sum of 2 quarters · filed 2026-05-11 | -$47.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.47M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $108.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.63M derived: sum of 3 quarters · filed 2026-08-10 | $8.47M 10-K · filed 2026-03-02 |
| 2025-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.70M derived: sum of 2 quarters · filed 2026-08-10 | $8.54M 10-Q · filed 2025-11-10 | $8.52M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $8.36M 10-Q · filed 2026-08-10 | $8.34M derived: sum of 3 quarters · filed 2026-08-10 | $8.39M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $6.84M 10-Q · filed 2026-05-11 | $6.83M derived: sum of 2 quarters · filed 2026-05-11 | $6.87M derived: sum of 3 quarters · filed 2026-05-11 | $6.94M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $30.00K derived: sum of 2 quarters · filed 2026-03-02 | $97.00K derived: sum of 3 quarters · filed 2026-03-02 | $97.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $113.00K derived: sum of 2 quarters · filed 2025-11-10 | $113.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $67.00K 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $107.00K 10-K · filed 2026-03-02 |